Assembly Biosciences, Inc. (ASMB): Capital Expenditures
$66.0K
Year ended 2025-12-31
$85.0K
Trailing 12 months to 2026-06-30
-13.5%
3-year compound annual growth
-32.5%
5-year compound annual growth
+1.3%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $66.0K | +135.7% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $28.0K | -89.0% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $255.0K | +150.0% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $102.0K | -96.7% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $3.10M | +558.7% | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | $470.0K | -69.8% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $1.55M | +357.1% | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | $340.0K | -60.7% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $865.0K | +488.4% | 2020-03-04, From 2017-01-01 |
| 2016-12-31 | $147.0K | +152.3% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $58.3K | -61.1% | 2018-03-08, From 2015-01-01 |
| 2014-12-31 | $150.0K | n/m | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $6.5K | +99.8% | 2015-03-16, From 2013-01-01 |
| 2012-12-31 | $3.2K | -72.9% | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $12.0K | n/a | 2013-03-18, From 2011-01-01 |
| 2010-12-31 | $0 | -100.0% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $2.6K | n/a | 2012-03-14, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $66.0K | +135.7% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $2.35M | +90.3% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $495.0K | -3.1% |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | $42.77M | -45.4% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $542.0K | -46.4% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $220.0K | -29.0% |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | $6.64M | n/m |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $333.0K | n/m |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $12.90M | -28.1% |
Compare ASMB, BCYC, VRDN, ABCL side by side · Screen every company in Pharmaceutical Preparations ↗